相关实验视频
Updated: May 5, 2026
07:30
Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
3.5K
在肥胖患者中,膜皮瘤切除术的有效性和安全性
Kamran Hassan Bhatti1, Aftab Ahmed Channa2, Nadeem Sohail1
1Urology Section, Al-Khor Hospital, Hamad Medical Corporation, Doha-Qatar.
Journal of Ayub Medical College, Abbottabad : JAMC
|November 25, 2024
概括
穿皮瘤切除术 (PCNL) 在卡塔尔的肥胖和非肥胖患者中同样有效. 这项研究没有发现石头清除或并发症等结果的显著差异,这表明PCNL是肥胖个体脏石头清除的可行选择.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 腎臟病學 (nephrology) 是一種醫學專業.
- 手术瘤学手术瘤学
背景情况:
- 肥胖是一个日益严重的全球健康问题,在卡塔尔的流行率很高.
- 卡塔尔面临尿病的风险因素增加,包括饮食和气候.
- 这项研究解决了评估对肥胖人口结石管理的手术选择的需要.
研究的目的:
- 评估皮肤穿神经切除术 (PCNL) 在肥胖患者与非肥胖患者的疗效.
- 为了比较这两个患者群体之间的关键手术结果.
主要方法:
- 在2015年至2019年期间接受PCNL的150名患者的回顾性评估.
- 患者被分为非肥胖 (BMI <30 kg/m2) 和肥胖 (BMI >30 kg/m2) 的两组.
- 石头清除,手术时间,住院时间,止痛药的使用和并发症的比较,使用奇平方测试和Clavien-Dindo分类.
主要成果:
- 肥胖和非肥胖群体之间在操作时间,光镜时间或访问站点参数中没有发现显著差异.
- 总住院时间,血红蛋白下降和并发症率在两组中都相似.
- 非肥胖患者的即时无石头率为81.8%,肥胖患者的即时无石头率为75% (p=0.21),表明效果相似.
结论:
- 苏平PCNL在非肥胖和肥胖患者之间表现出可比的疗效.
- 这项研究是第一个根据ERAS协议评估PCNL结果的研究,用于肥胖患者的仰卧姿势.
- 建议进行进一步的多中心和前性研究来验证这些发现.
相关概念视频
01:21Drug Dosing: Obese Patients
372
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
372
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
445
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
445
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
330
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
330
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention
764
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
764
01:25Urinary Tract Calculi VI: Surgical Management
1.0K
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
1.0K